ROME, Nov 20 (Reuters) - Private equity firm Cinven
secured a conditional approval from Italian authorities over its
plan to sell a 15% stake in diagnostic service provider Synlab
to laboratory operator Labcorp LH.N , a government document
sent to parliament showed.
Golden powers legislation requires Italian government
approval for any decision which results in changes in the
ownership, control or availability of strategic assets in the
country.
Italy's cabinet authorised the transaction on Nov. 12 with
some unspecified conditions, according to the document.
Announced in September, the deal is worth some 150 million
euros ($158.48 million).
($1 = 0.9465 euros)
(Reporting by Giuseppe Fonte, Editing by Louise Heavens)
((giuseppe.fonte@thomsonreuters.com; +390680307711;))